Member Info for ShearClass

Chill, the spread always catches up, it obviously can't always be bang in line... Interesting finish on the way here, would be great timing to get the care homes contract (For the country as well as NCYT!).

Wow, this share has been off the radar for a long time - it's interesting because they haven't raised cash for over 2 years and are now profitable, yet the market cap has declined from £35m to £6.5m... if they deliver a maiden profit as discussed in their recent trading update surely this gets back to 10p for starters? The purchase by HSBC of the Edward's Family's 20% stake suggests just this - they must be a distressed seller, and HSBC know the asset is fundamentally undervalued?

It's in full re-rate mode as people catch on to the opportunity here, the best thing is that it's a beautifully simple idea which is easy to understand. It's made mincemeat of the 60's, the question is how high does the current momentum take us? Wouldn't be surprised to see £1 in short order before any consolidation happens...

Amazed by how quiet this board remains after TWD's recent landmark contract win & resultant share price increase. I think this company is a diamond in the rough that is AIM. The recent proactive article below is a great bitesize intro to the company for anyone looking to learn more, £46m market cap with the world at it's feet :)

https://www.proactiveinvestors.co.uk/companies/news/931118/trackwise-designs-targeting-three--multi-billion-pound-industries-931118.html

It's clear that there are too many nervous PI's holding this stock for us to get a significant pre news rally - we may get something after 4pm tomorrow... I've never been in a share with so many low value odd numbered trades, both buys and sells. Many inexperienced newbies following the price movements and losing 9 times out of 10 would be my guess.

Confident that Carl & Paraytec will nail this, they are a very experienced team & it's obvious that progress is being made.

With the future of Polkadot looking so strong they should never have to raise capital again via a placing, on any sensible exchange this would be reflected in the share price!

Positive that it’s going to be listing in the next couple of weeks. The pathfinder doc disclosed Verici are raising £12m, it’s hard to think they would list at less than £50m if they are raising that much given the dilution that would occur to the existing RENX holding... My bet would be £60m post money valuation, so the £12m cash raised would equate to a 20% equity stake.

Company wise it looks solid, two patented products, one of which has no competitors & the other that is far superior to existing competition. Aiming to launch in the US, EU & UK.

Doubt I’ll bother with the open offer given we’ll receive Verici shares from the dividend in specie.

I expect it'll rise after 9am - double whammy for the Monday morning PI's who were spiked with a big gap yesterday, they're now being squeezed with a gap down today...20% losses being booked for some no doubt :(

Also this one last Thursday from Shares Mag; https://www.sharesmagazine.co.uk/article/novacyt-still-looks-really-cheap-despite-share-price-rally

Conclusion;

“So many small caps claim they are going places but often disappoint. In contrast, Novacyt is actually achieving tremendous sales numbers meaning the market excitement is justified. It’s in a sweet spot and investors should get on board now.”

Price at tip ; £6.32

If you were writing a textbook on AIM & wanted to depict the best way to generate PI sells it would look something like this morning - open up massively to get existing holders to take profit, spike new buyers & then aggressively drop the SP to get those new buyers to sell at a loss. Thus generating an excess of shares to fill the huge delayed buys...

Given the SNG target I’d be surprised if Numis have an NCYT target price below £25, but it could be a lot higher. One thing you can guarantee is that it won’t be at £8.

@robort, not seen an NCYT broker note yet that I've seen, but can't be too far away. I did wonder whether last weeks take off had been driven by something from either Numis or Oddo, but someone would have uncovered it by now! Certainly an interesting target for SNG, I'm waiting until they announce whether they will do a phase III trial before getting involved again...

An excellent days progress, as Newboy says I'm also amazed at the uptake pre FDA approval. If this continues in the next 6 months & accelerates once they have official approval then we're going to have a monster on our hands! A nice 100k delayed buy from 3pm has ticked through, free float must be rapidly diminishing given 63% is held by >3% holders + directors.

Usually when individuals claim they know everything and make prophetic statements about the future they are on the verge of tripping up ;) BRH could 50 bag, but there is no excuse for acting like a ballbag.

Disagree re. PCR - it all depends on the setting. Care Homes & Hospitals need 100% accuracy and speed is a secondary requirement, NCYT have excellent solutions in their portable Q16/32 product, hence the £406m UK government contract they won last week!

For sporting events, transport hubs, working environments etc speed is the critical factor, this is where rapid tests will excel & where BRH can make a difference. Any kind of moonshot involvement here would transform the market cap - 10 bags for starters.

Great to see the adoption of new machines continue, this gives them such a head start if/when they get FDA approval... The timing is also excellent as it looks as though 50p has been broken, you feel like it could re-rate at a significant pace from here.

On the verge of breaking 42...key level at present. Should be a very good few days here given the market cap vs potential of the newsflow!

Definitely not getting involved in an AIM share that rose from 35p to £1.75 before plummeting back to £1 based on an RNS that was supposedly positive! (It clearly wasn’t...)

@Orangutan, in terms of potential upside I’d say Braveheart (BRH) is worth a look over the weekend. £13m market cap at present but one of their 100% owned companies has been working on a rapid test with Sheffield University based on Aptamers. Proof of concept due Friday 16th. Scientific concept has been posted on Twitter by the professor working on it & looks very interesting; https://twitter.com/carlsmythe/status/1313042549548953602?s=21

Looking like we're going to get a strong finish, must be chunky delayed buys as nothing is showing yet... Next week could be fun.

Re. 50p, it's worth highlighting that in that aborted negotiation with Aptamer Group back in early May, the share price actually opened at 50p on 6th May, based on just the following;

Paraytec Limited ("Paraytec") (holding 100%)

"Paraytec are in discussions with Aptamer Group and the University of Sheffield to define a project to develop a COVID-19 test. If successful, this test would enable potentially infectious individuals to be identified quickly. Such a test could be used in airports, transport hubs, healthcare environments, large workplaces and similar settings, where rapid screening of large numbers of people for presence of the virus is required. Using Paraytec's imaging capability in partnership with aptamers from Aptamer Group which bind to the spike protein on the virus, the objective is to develop a portable test, which can generate a result in a matter of minutes from a swab provided at the test location and require no specialist skills to be operated."

They've basically followed that path, minus Aptamer Group, and are now 'well on the way' according to the Sheffield Uni professor. It's therefore a bit bonkers that you can currently buy at 37p, the reasons being a large holder selling out & Trevor Brown messing with his holding (although ultimately now holding more than before).

IMO we could open anywhere from 70p to over £1 on successful PoC, and we have the benefit of Professor Smyth providing supporting evidence of the tests capabilities, so risk / reward wise there can't be too many better ops on AIM in the very near term.